Evidence map›Paper›PMID 37267174›Full record

ArticleJournal of addiction medicine

Distress Tolerance in the Comorbid Chronic Pain and Opioid Use Disorder Population.

Sarah C Wilson, Jonathan A Shaffer, Amy B Wachholtz

Open access · greenAbstract read
In one paragraph

Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sarah C WilsonFrom the Department of Psychology, University of Colorado Denver, Denver, CO (SCW, JAS, ABW); Division of Addiction and Psychiatry, University of Colorado Medical School, Aurora, CO (ABW); and Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA (ABW).
Jonathan A Shaffer
Amy B Wachholtz
University of Colorado Denver · US

Funding

Advancing STOP: Self-regulation/CBT Therapy for Opioid addiction and PainR34DA041549 · NIDA · UNIVERSITY OF COLORADO DENVER · PI WACHHOLTZ, AMY B · 2017 to 2019
$722k
Co-Morbid Opioid Addiction and Chronic PainK23DA030397 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WACHHOLTZ, AMY B · 2011 to 2015
$685k
NIDA NIH HHS K23 DA030397NIDA NIH HHS R34 DA041549
6 · The paper itself

Abstract

objectivesThe risk of opioid addiction among people with chronic pain is elevated in those using opioids to self-medicate physical or emotional pain or distress. The purpose of this study is to test the main effect of distress tolerance (DT) on opioid use disorder (OUD) status in people with chronic pain, and the potential moderating effect of DT in the relationship between known addiction risk factors and the development of OUD.

methodsOne hundred twenty people with chronic pain were recruited to 1 of 3 groups according to their opioid use status (ie, current methadone or buprenorphine/naloxone for OUD [n = 60], history of OUD but current prolonged opioid abstinence [n = 30, mean abstinence = 121 weeks, SD = 23.3], and opioid naive [n = 30]). Participants completed self-report measures and a cold pressor task. Multinomial logistic regression analyses were used to test if DT associated with OUD status in people with chronic pain and to compare DT to other known indicators of OUD risk. Multinomial linear regression analyses were used to test the moderation effects of DT on the relationship between various risk factors and OUD in people with chronic pain.

resultsAnalyses revealed that DT was significantly related to OUD status but did not moderate the effects of most OUD risk factors.

conclusionsThese results suggest that decreasing distress (eg, pain levels, craving responses, etc) may be more effective than improving tolerance to distress for the comorbid chronic pain and OUD population.

Indexed as

BuprenorphineChronic PainOpioid-Related DisordersAnalgesics, OpioidBuprenorphine, Naloxone Drug CombinationHumansMethadoneOpiate Substitution TreatmentAnalgesics, OpioidBuprenorphineBuprenorphine, Naloxone Drug CombinationMethadone

Identifiers

PMID37267174
PMCPMC10148917
OpenAlexW4308370236

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.